The PennZone

  • Home
  • Non-profit
  • Education
  • Business
  • Technology
  • Construction
  • Health
  • Software
  • Entertainment

Utah attempts to legalize placenta cell therapy
The PennZone/10266985

Trending...
  • The AI Direction Deficit: TripleTen Study Finds Staff Get Told to Use AI — But Not Trained to Use It
  • Brewtay Coffee Partners with Alex's Lemonade Stand to Fuel Penn Wynne Volunteers
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
Parent's Guide to Cord Blood Foundation
Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

BROOKEVILLE, Md. - PennZone -- Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Parent's Guide to Cord Blood Foundation is a small non-profit in the biotech space. We are the first to break the story that the Utah state legislature did not realize what they were voting for when they passed Utah S.B. 199.

More on The PennZone
  • Filmmaker Preston A. Dent to Premiere "Harrisburg-The Movie" at Whitaker Center for the Arts
  • Pollock Begg Family Law Attorneys Earn 2026 Pennsylvania Super Lawyers Honors at Every Level
  • Research reveals "The Borderless Pay Standard," a 48-point gap between multinational employers and workers on transparent pay expectations
  • Global.ai Appoints Freedomtech Solutions as Specialist Partner for Agentic AI
  • Communities In Schools of Eastern Pennsylvania's Ready, Set, Graduate! Celebrates Over 100 Students in Two Ceremonies

The FDA still considers unapproved stem cell therapies to be illegal, and when it comes to drug regulations, federal law takes supremacy. This is not the same as states ignoring federal law and legalizing recreational drugs. In the case of stem cell therapy, patients that receive unregulated products with insufficient oversight could suffer serious adverse events. The new law Utah S.B. 199 is going to trigger a showdown between the federal government and Utah. Doctors who administer therapy to patients under the new Utah law could be sued by the Dept. of Justice. At a bare minimum, we are calling for the state of Utah to establish oversight of this arena before patients are hurt.

Contact
Frances Verter, PhD
***@parentsguidecordblood.org


Source: Parent's Guide to Cord Blood Foundation

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Joseph Nybyk (AKA Joseph Neibich) Guests On Octopus TV
  • Mutant-Fueled Bio-Cyberpunk Shooter HoverGrease 2 Launches May 22
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • FutureLot Powers ADU Wizard for Massachusetts Clean Energy Center's Statewide ADU Resource Center
  • ICT Innovations Releases ICTPBX Community Edition as Open Source Under Mozilla Public License 2.0
  • Brett Furman Expands AI and Marketing Team to Better Help Home Sellers Navigate the Future of Online Search
  • Maryland Personal Injury Firm Earns National Recognition in 2026 ELA Awards
  • Robert J. Bradshaw's AYE is a Gripping Dual Reality Thriller Exploring the Increasingly Blurred Line Between Humanity and Technology
  • Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
  • JFAB Consulting Elevates Brand with New Identity and Digital Experience
  • SteelTree Announces Launch of Its Operational Decision Intelligence Service
  • Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
  • AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
  • AI Predicts the Most Likely 2026 FIFA World Cup Winner
  • The AI Production Shift: Why Game Development Is Entering Its Most Accelerated Phase
  • World-First AI Humanoid Robot Debuts on Cherie Barber's Ground-breaking Australian Reno Show
  • New Survey Reveals America's Most Feared Bridges for Cyclists — Golden Gate Tops the List
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward

Popular on PennZone

  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • New plusOne Research Finds the Orgasm Gap Is a 30-Point Chasm — and Confirms It Isn't Biology
  • Strategic Talent Associates Launches THE ALIGNED RESET™
  • AWARENESS TO WELLNESS: Imhotep Institute Charter High School
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • New Homesites Released at Heritage at Manalapan Featuring Scenic Golf Course Views
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities

Similar on PennZone

  • NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
  • More Life Summit 2026 Announces Gary Brecka & Mr. Olympia Derek Lunsford as First Speakers for Miami Event
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
  • Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
  • Boston Industrial Solutions Expands Its Industry-Leading UV Ink Portfolio with the Launch of a Matte Ink - Natron® UVPZ
  • AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
  • NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us